These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

147 related articles for article (PubMed ID: 29039771)

  • 1. Integrated Process Modeling-A Process Validation Life Cycle Companion.
    Zahel T; Hauer S; Mueller EM; Murphy P; Abad S; Vasilieva E; Maurer D; Brocard C; Reinisch D; Sagmeister P; Herwig C
    Bioengineering (Basel); 2017 Oct; 4(4):. PubMed ID: 29039771
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Digital application for drug product potency target evaluation in biopharmaceutical manufacturing.
    Shen D; Panjwani S; Spetsieris K
    Biotechnol Prog; 2024; 40(4):e3461. PubMed ID: 38558405
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Holistic Design of Experiments Using an Integrated Process Model.
    Oberleitner T; Zahel T; Pretzner B; Herwig C
    Bioengineering (Basel); 2022 Nov; 9(11):. PubMed ID: 36354553
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Accurate definition of control strategies using cross validated stepwise regression and Monte Carlo simulation.
    Yang PY; Hui CJ; Tien DJ; Snowden AW; Derfus GE; Opel CF
    J Biotechnol; 2019; 306S():100006. PubMed ID: 34112369
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Quantitative CPP Evaluation from Risk Assessment Using Integrated Process Modeling.
    Borchert D; Zahel T; Thomassen YE; Herwig C; Suarez-Zuluaga DA
    Bioengineering (Basel); 2019 Dec; 6(4):. PubMed ID: 31847142
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Workflow for Criticality Assessment Applied in Biopharmaceutical Process Validation Stage 1.
    Zahel T; Marschall L; Abad S; Vasilieva E; Maurer D; Mueller EM; Murphy P; Natschläger T; Brocard C; Reinisch D; Sagmeister P; Herwig C
    Bioengineering (Basel); 2017 Oct; 4(4):. PubMed ID: 29023375
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Folic acid supplementation and malaria susceptibility and severity among people taking antifolate antimalarial drugs in endemic areas.
    Crider K; Williams J; Qi YP; Gutman J; Yeung L; Mai C; Finkelstain J; Mehta S; Pons-Duran C; Menéndez C; Moraleda C; Rogers L; Daniels K; Green P
    Cochrane Database Syst Rev; 2022 Feb; 2(2022):. PubMed ID: 36321557
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Integrated process model for the prediction of biopharmaceutical manufacturing chromatography and adjustment steps.
    Rischawy F; Briskot T; Schimek A; Wang G; Saleh D; Kluters S; Studts J; Hubbuch J
    J Chromatogr A; 2022 Oct; 1681():463421. PubMed ID: 36063778
    [TBL] [Abstract][Full Text] [Related]  

  • 9. QbD-guided pharmaceutical development of Pembrolizumab biosimilar candidate PSG-024 propelled to industry meeting primary requirements of comparability to Keytruda®.
    Jaffar-Aghaei M; Khanipour F; Maghsoudi A; Sarvestani R; Mohammadian M; Maleki M; Havasi F; Rahmani H; Karagah AH; Kazemali MR
    Eur J Pharm Sci; 2022 Jun; 173():106171. PubMed ID: 35378209
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Application of quality by design principles to the development and technology transfer of a major process improvement for the manufacture of a recombinant protein.
    Looby M; Ibarra N; Pierce JJ; Buckley K; O'Donovan E; Heenan M; Moran E; Farid SS; Baganz F
    Biotechnol Prog; 2011; 27(6):1718-29. PubMed ID: 21948302
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Proposal on How To Conduct a Biopharmaceutical Process Failure Mode and Effect Analysis (FMEA) as a Risk Assessment Tool.
    Zimmermann HF; Hentschel N
    PDA J Pharm Sci Technol; 2011; 65(5):506-12. PubMed ID: 22293839
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Stress Factors in Protein Drug Product Manufacturing and Their Impact on Product Quality.
    Das TK; Sreedhara A; Colandene JD; Chou DK; Filipe V; Grapentin C; Searles J; Christian TR; Narhi LO; Jiskoot W
    J Pharm Sci; 2022 Apr; 111(4):868-886. PubMed ID: 34563537
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Predictive Ppk calculations for biologics and vaccines using a Bayesian approach - a tutorial.
    Weusten J; Hu J
    Pharm Stat; 2024 Apr; ():. PubMed ID: 38603591
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Comprehensive Study of Intermediate and Critical Quality Attributes for Process Control of High-Shear Wet Granulation Using Multivariate Analysis and The Quality by Design Approach.
    Han JK; Shin BS; Choi DH
    Pharmaceutics; 2019 Jun; 11(6):. PubMed ID: 31159393
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Lifecycle management in pharmaceutical analysis: How to establish an efficient and relevant continued performance monitoring program.
    Ermer J; Aguiar D; Boden A; Ding B; Obeng D; Rose M; Vokrot J
    J Pharm Biomed Anal; 2020 Mar; 181():113051. PubMed ID: 31962246
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Stage 2 Process Performance Qualification (PPQ): a Scientific Approach to Determine the Number of PPQ Batches.
    Pazhayattil A; Alsmeyer D; Chen S; Hye M; Ingram M; Sanghvi P
    AAPS PharmSciTech; 2016 Aug; 17(4):829-33. PubMed ID: 26349690
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Process characterization and Design Space definition.
    Hakemeyer C; McKnight N; St John R; Meier S; Trexler-Schmidt M; Kelley B; Zettl F; Puskeiler R; Kleinjans A; Lim F; Wurth C
    Biologicals; 2016 Sep; 44(5):306-18. PubMed ID: 27464992
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Risk-based Methodology for Validation of Pharmaceutical Batch Processes.
    Wiles F
    PDA J Pharm Sci Technol; 2013; 67(4):387-98. PubMed ID: 23872447
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Specification-driven acceptance criteria for validation of biopharmaceutical processes.
    Marschall L; Taylor C; Zahel T; Kunzelmann M; Wiedenmann A; Presser B; Studts J; Herwig C
    Front Bioeng Biotechnol; 2022; 10():1010583. PubMed ID: 36213075
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A case study: application of statistical process control tool for determining process capability and sigma level.
    Chopra V; Bairagi M; Trivedi P; Nagar M
    PDA J Pharm Sci Technol; 2012; 66(2):98-115. PubMed ID: 22492596
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.